REIMAGINING ANTIBODY MEDICINES

DEAD

Serial Number

97846922

Owner

IGM Biosciences, Inc.

Attorney

Karen Feisthamel

Filing Date

Mar 20, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

REIMAGINING ANTIBODY MEDICINES Trademark

Serial Number: 97846922

REIMAGINING ANTIBODY MEDICINES is a trademark filed by IGM Biosciences, Inc. on March 20, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). The application is currently no longer active.

Trademark Classes

Class 36 - Insurance & Financial

Insurance; financial affairs; monetary affairs; real estate affairs

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Owner Contact Info

IGM Biosciences, Inc. (9 trademarks)

325 East Middlefield Road
Mountain View, CA 94043

Entity Type: 03

Legal Representation

Attorney of Record

Karen Feisthamel

690 trademarks filed View all →

Correspondence Address

Karen Feisthamel KDW FIRM PLLC

2601 WESTON PARKWAY, SUITE 103

CARY, NC 27513

United States

Trademark Details

Filing Date

March 20, 2023

Registration Date

Not Registered

Published for Opposition

November 19, 2024

Goods & Services

Education services, namely, arranging and conducting educational congresses in the field of antibodies and antibody research and development

Providing financial and investment information in the field of antibodies and antibody research and development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 4, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Aug 4, 2025 ABN6

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 31, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 19, 2024 NPUB

PUBLISHED FOR OPPOSITION

Nov 19, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 13, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 7, 2024 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 2, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 2, 2024 CRFA

ASSIGNED TO LIE

Oct 2, 2024 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 10, 2024 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Feb 21, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Feb 21, 2024 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 11, 2023 GNRN

NON-FINAL ACTION E-MAILED

Dec 11, 2023 GNRT

NON-FINAL ACTION WRITTEN

Dec 11, 2023 CNRT

ASSIGNED TO EXAMINER

Dec 11, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 11, 2023 NWOS

NEW APPLICATION ENTERED

Mar 23, 2023 NWAP

Related Trademarks

More from this Owner

GLOBAL LEADERS IN IGM ANTIBODIES

IGM BIOSCIENCES

Serial #97838076

IGM BIOSCIENCES

More in Same Class

COOSA MILL

WE HONOR VETERANS

BLUE CARDINAL HOME SERVICES

ENDURA

BENABLE

CERTUITY TRUST